RT Journal Article
SR Electronic
T1 Dyslipidemia in HIV patients
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 1113
OP 1120
VO 72
IS 12
A1 Tungsiripat, Marisa
A1 Aberg, Judith A.
YR 2005
UL http://www.ccjm.org/content/72/12/1113.abstract
AB Thanks to antiretroviral therapy, people with human immunodeficiency virus (HIV) infection are living longer, but as they do, non-HIV medical problems become more relevant. In particular, dyslipidemia, an important reversible risk factor for cardiovascular disease, has been linked to HIV infection and its treatment. Although controversy remains as to whether people with HIV infections will develop premature coronary heart disease, it seems prudent to manage dyslipidemia in these patients just as we do in our HIV-negative patients. Interactions between lipid-lowering drugs and antiretroviral drugs require special attention.